Access Alternative Investments, Inc. is a platform that curates and distributes institutional-quality alternative investment opportunities in asset classes such as aviation, maritime, and real estate, specifically for accredited investors. By leveraging a team with extensive Wall Street experience, the platform addresses the lack of access to these unique investment options, enhancing portfolio diversification and potential returns.

Antheia utilizes synthetic biology to manufacture biosynthetic Key Starting Materials (KSMs) and Active Pharmaceutical Ingredients (APIs) for essential medicines, enhancing the reliability and efficiency of pharmaceutical supply chains. This approach mitigates the risks of drug shortages caused by unpredictable agricultural sources and environmental factors.

Apriori Bio develops a platform for creating variant-resilient vaccines using real-time data analytics to enhance preparedness for viral outbreaks. This technology enables rapid adaptation to emerging viral threats, ensuring effective immunization strategies in response to evolving pathogens.

Develops the ATOM H1, a hardware device that integrates with cameras to create cryptographically signed images, ensuring authenticity through unique sensor fingerprinting and secure data binding. This technology addresses the growing need for verifiable digital media by enabling photographers, organizations, and platforms to capture, store, and share trusted images, preventing misuse and distortion in an era of pervasive digital manipulation.

BugSeq Bioinformatics offers a fully automated bioinformatics platform that enables microbiology labs to perform rapid and accurate sequencing analysis, delivering actionable results within an hour. The platform addresses the need for efficient pathogen identification and antimicrobial resistance prediction, streamlining workflows for labs of all sizes.

Centivax develops broad-spectrum vaccines aimed at preventing infectious diseases across different species. Their current focus is on a universal influenza vaccine currently in pre-clinical development for ferrets and pigs. The company seeks to advance global health by creating preventative measures against widespread pathogens.

Cytovale has developed the IntelliSep test, an FDA-cleared diagnostic tool that analyzes the biomechanical properties of white blood cells from a standard blood draw to assess a patient's risk of sepsis within 8 minutes. This rapid detection addresses the critical challenge of timely diagnosis in sepsis, a condition that increases mortality by 8% for every hour treatment is delayed.

Disclo offers patented software that automates the ADA Interactive Process for workplace accommodations, ensuring compliance and efficiency in handling requests from employees and candidates. By integrating with existing HR systems, Disclo reduces administrative burdens and enhances employee satisfaction through streamlined workflows and expert support.

Pioneers precision immunology by developing patient-specific therapies that prioritize individual biological responses over traditional molecule-first approaches. This method addresses the limitations of generic treatments for immune-mediated diseases, aiming to deliver more effective and personalized therapeutic options.

ERC System develops a hybrid-electric aviation platform capable of vertical take-off and landing (eVTOL). This platform is engineered for cost-efficient operation, significantly outperforming helicopters in operating costs. The system provides extended range and substantially faster travel times compared to ground transportation for critical missions.

Eubiologics designs and deploys engineered microbial consortia that metabolize persistent organic pollutants in soil and groundwater, using genome‑scale modeling and adaptive evolution to achieve high‑rate degradation under site‑specific conditions. The platform integrates in‑situ biosensor strains, GIS‑driven inoculum placement, and cloud‑based analytics to provide real‑time performance monitoring and reduce remediation timelines and costs for contractors, industrial owners, and regulatory agencies.

H Company develops AI models, including VLMs and LLMs, to automate web processes and enhance decision-making for businesses. Their technology increases worker productivity by streamlining repetitive tasks and improving operational efficiency.

Heal is a nonprofit ecommerce platform that utilizes experience-based peer support to help individuals with mental illness reconnect with their passions through creative expression. By empowering emerging artists to showcase their work, Heal reinvests 100% of its profits into community-building initiatives that foster meaningful connections.

JUMPCODE offers CRISPR-mediated rRNA depletion kits, including DepleteX™ and CRISPRclean®, that enhance next-generation sequencing (NGS) workflows by removing uninformative nucleic acids. This technology improves sensitivity and data quality across various genomic applications, including single-cell analysis and microbiome characterization.

Provides a finance-specific AI-powered search engine that leverages hybrid search models and specialized embeddings to deliver hyper-accurate insights for equity research. This tool enables hedge funds and asset managers to quickly identify relevant data, trends, and cross-sector impacts, improving decision-making and productivity during critical analysis periods like earnings reports.

Provides a shared progress tracking platform for coaches and clients, enabling clients to log actions, track goals, and maintain accountability between sessions. Coaches gain measurable insights into client progress and engagement through customizable logs, reminders, and real-time feedback tools, improving the effectiveness of their practice.

MBD Financials provides a unified Web3 platform that combines DeFi services, a multivendor marketplace for NFTs and tokenized real-world assets, and provably fair gaming. Users can trade digital and physical goods, earn yields, and convert in‑game rewards into gold‑backed NFTs, all managed through a single wallet interface.

Micron Biomedical, Inc. utilizes a proprietary dissolvable microarray technology to deliver vaccines and therapeutics without needles, enabling painless self-administration. This approach addresses the challenges of cold chain logistics, reduces medical waste, and increases access to life-saving medications for individuals in various settings.

Monod Bio develops computational protein design tools utilizing artificial intelligence to advance life sciences and clinical diagnostics. The company offers specialized products like NovoBody, LuxSit™ Pro, and NovoLISA for protein engineering applications. Their platform enables the creation of novel proteins with desired functionalities for various biological uses.

Ox provides a Human-Centered Automation platform that integrates with existing warehouse systems to create AI-powered workflows, enhancing frontline productivity and reducing training times. By focusing on the operator experience, Ox addresses the challenge of inefficient manual processes in supply chain operations, enabling companies to optimize their workforce and improve operational efficiency.

Path is an SEC-registered robo-advisor that automates cryptocurrency portfolio management through risk-adjusted asset allocation and long-term investment strategies. The platform simplifies digital asset investing for both novice and experienced users by offering personalized portfolio options and automated rebalancing.

Resi utilizes aerial surveys and artificial intelligence to conduct environmental data collection, significantly reducing survey time by up to 90% compared to traditional methods. This approach enhances data accuracy and safety while lowering acquisition costs to as little as 25-50% of conventional survey techniques.

Provides a real-time animation platform that uses state-driven animation and interactive design tools to create production-ready graphics for games, apps, and websites. By eliminating the need for hard-coded animations, it enables teams to streamline workflows, improve iteration speed, and deliver high-quality, responsive visual experiences across multiple platforms.

Serum is a decentralized exchange (DEX) platform that facilitates peer-to-peer trading of digital assets without the need for intermediaries. It addresses the lack of transparency and security in traditional trading systems by enabling users to maintain control of their funds and execute trades directly on the blockchain.